Oroville planning commission denies AEGIS outpatient treatment center permit at 1121 Oro Dam Boulevard

The Oroville Planning Commission on an evening vote denied a use permit for an AEGIS outpatient opioid treatment clinic proposed for 1121 Oro Dam Boulevard, approving a denial motion 6–0 with one commissioner recused.

The commission’s decision follows a staff presentation that summarized the applicant’s plan to convert roughly half of a 5,500-square-foot retail building into medical offices, operate primarily from about 5 a.m. to 1 p.m. daily with 15–20 employees, add an ADA path to the Caltrans sidewalk, restripe the parking lot, remove two conex containers and secure the trash enclosure. Staff also reported new materials in the packet, including a letter noting ADA protections for clinic clients, operational data from other AEGIS sites, local traffic counts for Highway 162 and correspondence about enforcement at other AEGIS locations.

The staff presentation said a preponderance of staff did not support this location for the clinic. The packet included two draft resolutions — one of approval and one of denial — and the commission was given the option to accept, modify or reject those resolutions. After public comment and questions of staff and the applicant, a commissioner moved to deny the application on grounds including incompatibility with surrounding land uses, inadequate site design and operational safety safeguards and potential adverse impacts on public health and safety; another commissioner seconded the motion. The motion carried 6–0 with one recusal. Staff advised the applicant that an appeal to the City Council must be filed within 15 days.

Why it matters: commissioners, law enforcement and nearby business owners repeatedly raised concerns about placing an opioid treatment clinic on a busy state highway where early‑morning, high‑volume patient visits could concentrate and where pedestrians already cross outside marked crosswalks. Supporters said the clinic would reduce travel burdens for local patients who currently go to Chico for medication and argued that treatment lowers crime and is highly regulated.

At the hearing, Amy, identified as AEGIS’ regional director for Northern California, said AEGIS “specialize[s] in substance abuse disorder” and that the organization “literally save[s] lives every single day.” Becca Mitchell, identified on the phone as AEGIS’ vice president, said AEGIS serves patients with methadone, buprenorphine and newer options and that, at other sites, most patients obtain take‑home doses after stabilization. AEGIS representatives said about 90 Oroville residents currently travel to Chico for treatment.

Multiple nearby business owners and residents spoke against the chosen site. Speakers cited active encampments and ongoing disturbances at the vacant retail building and said a staffed, regulated medical clinic might nevertheless create pedestrian safety and business‑impact issues because of the site’s location on Highway 162 (Oro Dam Boulevard). Several commenters said a medical zoning area near the hospital or Doves Landing would be a more appropriate location.

The police chief told commissioners he was unable to predict precise impacts because the clinic’s client mode of arrival (drive, bus or walking) and final operating details were not specified, but he said the commission should consider the compressed window of operations, the existing high traffic volumes and documented illegal pedestrian crossings in the corridor.

Support letters and materials in the packet included landlord endorsements, arrest data around other AEGIS clinics, Caltrans 2023 traffic counts for Highway 162 and correspondence from other jurisdictions describing enforcement and operational issues at some AEGIS locations. Staff also reported local research that identified two county‑operated clinics in Oroville that provide counseling and support and refer patients to AEGIS in Chico for medication.

Next steps: the denial will be reflected in a written determination. Staff told the applicant the appeal deadline is 15 days under the municipal code; the commission’s denial will be included with the record if the applicant appeals to City Council.

The commission adjourned its business after the hearing and noted upcoming items including a planned utility‑scale solar project and an annexation study scheduled for future meetings.